Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

DISCONTINUED OPERATIONS AND DECONSOLIDATION - Disclosure of results of discontinued operations (Details)

v3.25.1
DISCONTINUED OPERATIONS AND DECONSOLIDATION - Disclosure of results of discontinued operations (Details) - CAD ($)
$ in Thousands
12 Months Ended
Nov. 06, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of analysis of single amount of discontinued operations [line items]        
Revenue   $ 54,031 $ 48,804 $ 54,335
Cost of revenue   45,580 37,974 43,044
Gross profit before fair value adjustments   8,451 10,830 11,291
Fair value adjustments:        
Unrealized change in fair value of biological assets   0 0 (315)
Realized fair value adjustments on inventory sold or impaired   0 (984) (1,814)
Total fair value adjustments   0 (984) (2,129)
Gross profit   8,451 9,846 9,162
General and administrative expenses   8,018 11,008 21,460
Selling and marketing expenses   7,069 10,788 11,473
Restructuring expenses   0 617 4,383
Share-based compensation   369 225 2,637
Total operating expenses   18,685 22,638 39,953
Operating loss   (10,234) (12,792) (30,791)
Finance expenses, net   (2,560) 3,335 4,731
Loss before taxes on income (tax benefit)   (12,794) (9,457) (26,060)
Taxes on income (tax benefit)   (1,023) 771 (1,138)
Net loss from discontinued operations, net of tax   0 $ 0 $ (166,379)
Discontinued operations [member]        
Disclosure of analysis of single amount of discontinued operations [line items]        
Revenue $ 28,171      
Cost of revenue 24,227      
Gross profit before fair value adjustments 3,944      
Fair value adjustments:        
Unrealized change in fair value of biological assets (399)      
Realized fair value adjustments on inventory sold or impaired (2,528)    
Total fair value adjustments (2,129)      
Gross profit 1,815      
General and administrative expenses 38,464      
Impairment of goodwill, intangible assets, right-of-use assets and fixed assets 115,112      
Selling and marketing expenses 4,912      
Restructuring expenses 4,506      
Share-based compensation 1,130      
Total operating expenses 164,124      
Operating loss (162,309)      
Finance expenses, net (5,264)      
Loss before taxes on income (tax benefit) (167,573)      
Taxes on income (tax benefit) (1,194)      
Net loss from discontinued operations, net of tax $ (166,379)